Skip to main content
. 2020 May 21;123(3):410–417. doi: 10.1038/s41416-020-0902-y

Fig. 1. Flowchart of the processes for developing and validating the prognosis signature.

Fig. 1

The first step is to construct a prognostic signature for the relapse risk of stage II CRC. The second step is to verify the prognostic signature through ROC analysis, survival analysis and multi-dimensional omics analysis.